Type 2 diabetes mellitus (T2DM) is another proteinopathy with an alarming prevalence rate of 536 million worldwide, characterized by peripheral insulin resistance, high blood glucose levels and increased insulin secretion, which in time lead to a diminishment of β-cell functionality and number (Sun et al., 2022). This evidence concerns the gene INS and type 2 diabetes mellitus.